Cookie Consent by Free Privacy Policy Generator Horvath: 66% of pharmaceutical and biotech executives anticipate solid profit growth in 2025 | DoingBusiness.ro
loader
Horvath: 66% of pharmaceutical and biotech executives anticipate solid profit growth in 2025

Horvath: 66% of pharmaceutical and biotech executives anticipate solid profit growth in 2025

According to a study conducted by Horvath, 66% of executives in this sector expect profit growth of over 5% in 2025 and 2026

  • 70% of executives believe that artificial intelligence (AI) will significantly transform business models. 
  • 60% identify administrative cost reductions as the main driver of profit growth. 
  • Only 14% of companies expect an increase in the number of employees in 2025.

For more information, please see the Romanian version of the article, here.

 

Authors

foto
HORVATH ROMANIA
   Update cookies preferences